Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-24

Clinical Trial Update: Treatment of High Altitude Polycythemia by Acetazolamide [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating acetazolamide for high-altitude polycythemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: Association pour la Recherche en Physiologie de l'Environnement | Conditions: High Altitude Polycythemia | Phase 4 | Status: COMPLETED